Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
This role presents a rare opportunity to be one of founding members of the pricing and contracting operations team at Scholar Rock. Reporting directly to the Head of Market Access Finance, you'll act as a hands-on second-in-command: owning day-to-day management across pricing and contract operations as well as Gross-to-Net (GTN), while helping shape the team that will grow around you. If you want visible, high-impact work with a direct line to Finance and executive leadership, this is a place to make a real difference and make your mark on how a launch-stage biotech runs pricing operations.
Position Responsibilities
- Own gross-to-net (GTN) actuals-to-forecast reconciliation, including variance investigation and root-cause analysis
- Build reporting and analytics tools with automated validations across GTN, GP, and commercial and government rebates to strengthen oversight and surface actionable insights
- Coordinate business process outsourcing (BPO) partners, serving as the first-line escalation point
- Build contract analytics capabilities to support contract performance monitoring and decision-making
- Monitor IRA implementation, CMS rule-making and other policy changes; assess and communicate business impact to the Pricing Committee where relevant
- Manage BPO state price transparency reporting across applicable jurisdictions and monitor the evolving state regulatory landscape for new filing mandates
- Maintain the ex-US list/net price reference database supporting international reference pricing (IRP) analysis and global price corridor monitoring
- Maintain the global price master and price change-control process. Ensure list price changes, launch prices, and affiliate/distributor prices are approved under the pricing delegation of authority, documented, and accurately reflected in downstream systems
- Oversee revenue-leakage mitigation across contracting and compliance, including chargeback and duplicate-discount mitigation, rebate non-compliance, and price-calculation risk
- Manage rebate and chargeback processing and dispute resolution, ensuring accurate, timely, and auditable transactions
- Partner with Finance/FP&A and Accounting on quarterly GTN accruals and forecast assumptions (rebates, fees, discounts, utilization, and customer mix)
- Strengthen SOX-aligned controls and documentation across contracting and pricing operations
- Prepare deal models and policy impact analyses for Market Access and the Pricing Committee
- Own and optimize pricing and contracting data for analysis
- Evaluate, gain approval for, and implement a duplicate discount vendor solution
- Help build the evidence-based case for Phase 2 hiring and scaling of the function
- Lead and mentor analysts as the team scales, establishing best practices and a center-of-excellence approach
Candidate Requirements
- Bachelor's degree required; advanced degree (MBA) and/or CPA a plus
- 8+ years of pharmaceutical/biotech market access experience spanning government and commercial pricing, contracting, and GTN analytics
- Excellent GTN modeling, contract analytics, and financial-modeling skills; advanced Excel; comfort with reporting/BI/dashboard tools (e.g., Power BI, Tableau, SQL) strongly preferred
- Strong working knowledge of AMP, ASP, Best Price, URA, 340B, Medicaid, Medicare Part B and D, FSS/VA and trade channel dynamics
- Demonstrated experience managing third-party/BPO partners and transitioning or implementing operational projects
- Familiarity with duplicate discount vendors (e.g., BRG, Kalderos etc.)
- Experience supporting product launches or late-stage pipeline assets
- Understanding of SOX controls and auditable operations in a public-company environment
- Excellent communication and executive-presentation skills; thrives in a fast-paced, build-oriented biotech
Skills Required
- Bachelor's degree
- 8+ years of pharmaceutical or biotech market access experience spanning government and commercial pricing, contracting, and gross-to-net analytics
- Excellent gross-to-net modeling, contract analytics, and financial modeling skills
- Advanced Microsoft Excel skills
- Comfort with reporting and business intelligence dashboard tools such as Power BI, Tableau, or SQL
- Working knowledge of AMP, ASP, Best Price, URA, 340B, Medicaid, Medicare Part B and D, FSS/VA, and trade channel dynamics
- Experience managing third-party or BPO partners
- Experience transitioning or implementing operational projects
- Familiarity with duplicate discount vendors such as BRG or Kalderos
- Experience supporting product launches or late-stage pipeline assets
- Understanding of SOX controls and auditable operations in a public-company environment
- Excellent communication and executive-presentation skills
- MBA and/or CPA
What We Do
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy
